Recordati Industria Chimica e Farmaceutica
Global pharma group developing drugs for common/rare diseases & supplying APIs worldwide.
REC | XMIL
Overview
Corporate Details
- ISIN(s):
- IT0003828271 (+4 more)
- LEI:
- 815600FBF92FD3531704
- Country:
- Italy
- Address:
- VIA MATTEO CIVITALI, 1, 20148 MILANO
- Website:
- https://recordati.com/it/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Recordati Industria Chimica e Farmaceutica is an international pharmaceutical group dedicated to the research, development, manufacturing, and marketing of pharmaceuticals. With a history of nearly 100 years, the company develops and commercializes drugs for both common pathologies and rare diseases, operating in approximately 150 countries. Its business model integrates a chemicals division that produces and supplies Active Pharmaceutical Ingredients (APIs) to a global customer base alongside its core pharmaceutical operations. The group focuses on improving the health and quality of life for patients worldwide.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-11-14 11:28 |
Regulatory News Service
Interim report first nine months 2025
|
Italian | 1.3 MB | ||
| 2025-11-14 11:26 |
Regulatory News Service
Relazione primi nove mesi 2025
|
Italian | 1.1 MB | ||
| 2025-11-12 13:00 |
Regulatory News Service
Presentazione “First Nine Months 2025 Results”
|
Italian | 865.7 KB | ||
| 2025-11-11 20:48 |
Regulatory News Service
Directors’ report on the distribution of an interim dividend and interim financ…
|
Italian | 1.4 MB | ||
| 2025-11-11 20:47 |
Regulatory News Service
Relazione Amministratori sulla distribuzione di un acconto sui dividendi e pros…
|
Italian | 1.2 MB | ||
| 2025-11-11 20:42 |
Regulatory News Service
RECORDATI FIRST NINE MONTHS 2025 RESULTS: REVENUE +12.2%, EBITDA +11.8%, ADJUST…
|
Italian | 463.7 KB | ||
| 2025-11-11 20:40 |
Regulatory News Service
RISULTATI RECORDATI PER I PRIMI NOVE MESI DEL 2025: RICAVI +12,2%, EBITDA +11,8…
|
Italian | 481.1 KB | ||
| 2025-11-05 19:02 |
Director's Dealing
Allegato 3F
|
Italian | 29.3 KB | ||
| 2025-10-27 19:48 |
Transaction in Own Shares
RECORDATI: Update on the execution of the share buy-back program. Conclusion of…
|
English | 532.8 KB | ||
| 2025-10-27 19:47 |
Transaction in Own Shares
RECORDATI: Aggiornamento sull’esecuzione del programma di acquisto di azioni pr…
|
English | 510.5 KB | ||
| 2025-10-23 10:02 |
Board/Management Information
RECORDATI APPOINTS MIKE MCCLELLAN AS NEW CHIEF FINANCIAL OFFICER
|
English | 171.0 KB | ||
| 2025-10-23 10:00 |
Board/Management Information
RECORDATI NOMINA MIKE MCCLELLAN NUOVO CHIEF FINANCIAL OFFICER
|
Italian | 169.1 KB | ||
| 2025-10-21 20:08 |
Transaction in Own Shares
RECORDATI: Update on the execution of the share buy-back program
|
English | 779.6 KB | ||
| 2025-10-21 20:06 |
Transaction in Own Shares
RECORDATI: Aggiornamento sull’esecuzione del programma di acquisto di azioni pr…
|
Italian | 755.9 KB | ||
| 2025-10-14 20:11 |
Transaction in Own Shares
RECORDATI: Update on the execution of the share buy-back program
|
English | 241.5 KB |
Automate Your Workflow. Get a real-time feed of all Recordati Industria Chimica e Farmaceutica filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Recordati Industria Chimica e Farmaceutica
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Recordati Industria Chimica e Farmaceutica via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
